[1471]
Acremonium strictum Fungaemia in a Paediatric Patient with Acute ...
[19,4 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1472]
Risk of Childhood Leukaemia in the Vicinity of Nuclear ...
[40,9 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1473]
Transgenerational susceptibility to leukaemia induction resulting ...
[19,7 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1474]
Microsatellite instability in acute myelocytic leukaemia developed ...
[19,8 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1475]
Membranoproliferative glomerulonephritis in association with ...
[20,1 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1476]
Susceptibility to radiation-induced leukaemia/lymphoma is ...
[20,5 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1477]
Induction of osteosarcoma and acute myeloid leukaemia in CBA/H ...
[21,2 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1478]
The Treatment of Acute Lymphoblastic Leukaemia in the Elderly
[19,7 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1479]
Flavopiridol Induces Apoptosis in B-cell Chronic Lymphocytic ...
[20,8 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1480]
Acute Megakaryoblastic Leukaemia: A National Clinical and ...
[20,9 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1481]
Learning difficulties in children treated for acute lymphoblastic ...
[19,7 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1482]
p73 Status in B-cell Chronic Lymphocytic Leukaemia
[19,9 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1483]
A Systematic Overview of Chemotherapy Effects in Acute Myeloid ...
[50,5 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1484]
Successful Outcome of Pregnancy in Chronic Myeloid Leukaemia ...
[18,5 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1485]
Adult Hypocellular Acute Leukaemia with Lymphoid Differentiation
[20,4 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1486]
B cell chronic lymphocytic leukaemia cells have reduced capacity ...
[20,1 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1487]
Fetal abnormality associated with maternal acute lymphoblastic ...
[18,2 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1488]
Induction of the pro-myelocytic leukaemia gene by type I and type ...
[19,5 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1489]
Acute megakaryoblastic leukaemia in pregnancy presenting as ...
[18,3 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1490]
Comparative effects of cycloguanil and WR99210 in human leukaemia ...
[18,2 KB]
From [taylorandfrancis.metapress.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1491]
Clustering of childhood acute leukaemia
[16,7 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1492]
Chemotherapy for leukaemia following previous pelvic radiotherapy ...
[17,6 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1493]
Acute megakaryoblastic leukaemia with extreme thrombocytosis and ...
[18,2 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1494]
Cellular immune responses in acute leukaemia patients with severe ...
[18,0 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1495]
Active and indolent chronic lymphocytic leukaemia ± immune and ...
[17,8 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1496]
Physical performance in long-term survivors of acute leukaemia in ...
[17,2 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1497]
Changes in coagulation and ®brinolysis in childhood acute ...
[18,0 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1498]
Sequential production of leukaemia inhibitory factor by blood cell ...
[17,8 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1499]
Neurophysiological ®ndings in long-term survivors of acute ...
[19,6 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
[1500]
Cellular immune responses to autologous chronic myelogenous ...
[17,9 KB]
From [www.springerlink.com] Last viewed: 13.07.2004
ADULT LEUKAEMIA WORKING PARTY
SERIOUS ADVERSE EVENT REPORT
Patient Identification:
Name:
.
Trial
No:
.
Centre:
.
Consultant:
.
Associated Drug:
Trial:
PT1:
Anagrelide
AML:
ATRA
Fludarabine
PSC-833
HD
AraC
(A400)
Other:
.
Adverse Event:
Definition:- A
severe adverse event is any unexpected event, which may be related
to the drug, which is (a) life threatening, or (b) requires admission to
hospital, or (c) results in significant disability, or (d) results in cancer.
SAE: .
Details:
Found 1506 documents
Page 50 of 51 Pages:
<< < 41 42 43 44 45 46 47 48 49 50 51 > >>
cancers
homepage
last week